CynergisTek (NYSEAMERICAN:CTEK)‘s stock had its “buy” rating restated by research analysts at B. Riley in a research report issued on Thursday.
A number of other brokerages have also recently weighed in on CTEK. Roth Capital began coverage on shares of CynergisTek in a report on Monday, January 29th. They issued a “buy” rating and a $7.20 price objective for the company. Zacks Investment Research cut shares of CynergisTek from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th.
Shares of CynergisTek stock opened at $4.85 on Thursday. CynergisTek has a 12-month low of $2.70 and a 12-month high of $6.72. The firm has a market cap of $47.51, a PE ratio of 8.22 and a beta of 0.86.
ILLEGAL ACTIVITY WARNING: “CynergisTek (CTEK) Earns “Buy” Rating from B. Riley” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3298768/cynergistek-ctek-earns-buy-rating-from-b-riley.html.
CynergisTek Company Profile
Cynergistek, Inc provides outsourced document management services and IT security consulting services primarily to the healthcare industry in the United States. It offers workflow solutions; and creates manageable, dependable print management programs by managing the back-office processes of hospital clients.
Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.